Non-Invasive Transcutaneous Bioconductance Measurement as a Risk-Stratification Biomarker for Suspicious Pulmonary Lesions: Results of Plw-216 Prospective, Multi-Center Open Study to Evaluate the Clinical Efficacy and Safety of the Bioconductance Scan Platform (Prolung Test)